Bellicum Pharmaceuticals

173 articles about Bellicum Pharmaceuticals

• Bellicum To Present At The Ladenburg Thalmann 2016 Healthcare Conference

  9/20/2016

• Bellicum To Present At The Biocentury 23rd Annual Newsmakers In The Biotech Industry Conference

  9/1/2016

• 2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now

  8/19/2016

• BioLife Solutions, Inc. Executes 10 Year Supply Agreement With Bellicum For CryoStor Use In Cellular Immunotherapies

  8/10/2016

• Bellicum Reports Second Quarter 2016 Financial Results And Provides Corporate Update

  8/9/2016

• Bellicum Announces BPX-501 European Regulatory Updates

  8/5/2016

• Bellicum To Report Second Quarter 2016 Financial Results And Host Conference Call And Webcast On August 8, 2016

  8/1/2016

• Bellicum Announces Patent On CaspaCIDe Method For Selectively Eliminating Therapeutic Cells

  7/20/2016

• Bellicum Enters Into Research Collaboration With Leiden University Medical Center To Discover Natural High-Affinity TCRs

  6/2/2016

• Bellicum To Present At The Jefferies 2016 Global Healthcare Conference

  6/1/2016

• Bellicum Announces Data Presentations At The Annual Meetings Of The ASCO And The European Hematology Association

  5/19/2016

• Bellicum Appoints Jim Daly To Its Board Of Directors

  5/18/2016

• Bellicum Reports First Quarter 2016 Financial Results

  5/10/2016

• Bellicum To Present At The Bank of America Merrill Lynch 2016 Health Care Conference

  5/5/2016

• Bellicum Announces Late-Breaking Poster Presentation On TCR Product Candidate With Activation Switch At The AACR 2016 Annual Meeting

  4/18/2016

• Bellicum Announces BPX-501 Clinical Data Updates

  4/5/2016

• Bellicum Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2015

  3/15/2016

• Bellicum To Present At The Barclays Global Healthcare Conference

  3/8/2016

• Bellicum To Report Fourth Quarter And Full Year 2015 Financial Results And Host Conference Call And Webcast On March 14, 2016

  3/3/2016

• FDA Grants Orphan Drug Designation To Bellicum’s BPX-501 For The Treatment Of Immunodeficiency And GvHD Following Stem Cell Transplant

  2/22/2016